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Abstract: In this paper, we discuss hybrid decision support to monitor atrial fibrillation for stroke1
prevention. Hybrid decision support takes the form of human experts and machine algorithm2
working cooperatively on a diagnosis. The link to stroke prevention comes from the fact that3
patients with Atrial Fibrillation (AF) have a fivefold increased stroke risk. Early diagnosis, which4
leads to adequate AF treatment, can decrease the stroke risk by 66% and thereby prevent stroke.5
The monitoring service is based on Heart Rate (HR) measurements. The resulting signals are6
communicated and stored with Internet of Things (IoT) technology. A Deep Learning (DL) algorithm7
automatically estimates the AF probability. Based on this technology, we can offer four distinct8
services to healthcare providers: 1) universal access to patient data; 2) automated AF detection and9
alarm; 3) physician support; and 4) feedback channels. These four services create an environment10
where physicians can work symbiotically with machine algorithms to establish and communicate a11
high quality AF diagnosis.12
Keywords: Human and AI collaboration; Medical diagnosis support; Deep learning; Symbiotic13
analysis process; human controlled machine work14
1. Introduction15
Cerebrovascular accidents, commonly known as strokes, are the second most deadly disease and16
a leading cause of disability [1]. Ischemic stroke is the most common type of stroke, which accounts17
for ≈80% of all strokes [2]. This type of stroke occurs when the bloodstream, to any part of the brain,18
is blocked by blood clots [3]. When this occurs, brain tissue might get damaged, because the oxygen19
supply is interrupted. That damage can result in death or disability. Around 75% of all strokes happen20
in people aged 65 years or older. A meta study from 2009 shows that, within one year, 20000 UK21
citizens, aged 45 years and below, had a stroke [4]. Worldwide stroke causes around 5.7 million deaths22
annually, while in the UK around 150,000 people suffer a stroke per year out of which 53,000 people23
died [5]. The incidence rate of stroke in males is about 9% of the overall deaths in the UK, the same24
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measure for woman is around 13% [6]. The Framingham Heart Study showed a connection between25
Atrial Fibrillation (AF) and ischemic stroke [7]. To be specific, the severity of strokes, in people with26
AF, is higher and a stroke has worse outcome for people with AF when compared to people without27
AF. AF increases the probability of having a stroke fivefold, when compared to subjects without AF28
[7]. The link between AF and stroke is significant, because AF is the most common heart rhythm29
(arrhythmia) disorder which affects about 1% of the population [8]. The prevalence of AF increases30
with age [9,10]. NHS England estimates that only about 79% of all AF cases are diagnosed [11]. One31
reason for this low detection rate comes from the fact that AF is diagnosed based on heart rhythm32
irregularities and these irregularities might be intermittent (paroxysmal) [12] and some forms of AF33
are even asymptomatic [13]. If an observation coincides with a symptom-free period, then the disease34
cannot be diagnosed. Hence, a reliable AF diagnosis requires long-term monitoring of the human35
heart [14,15].36
Long-term AF monitoring can be done by measuring the electrical activity of the human heart37
via a non-invasive Electrocardiogram (ECG). So-called Holter monitors are used for this task and the38
resulting ECG measurements are most often used for AF detection [16]. However, the measurement39
setup is complex because electrical signals are susceptible to noise. Twelve electrodes are routinely40
deployed by specialized technicians during ECG measurements [17]. Furthermore, ECG signals have a41
high data rate, which makes them difficult and expensive to distribute and process in real-time. Using42
Heart Rate (HR), instead of ECG signals, can help to overcome these difficulties [18]. As such, HR43
signals are composed of beat-to-beat (RR) intervals. Detecting only the R peak makes the measurement44
setup less susceptible to noise and hence less complex. Furthermore, a heartbeat occurs about once45
every second, hence a HR signal communicates around one sample per second. Compared to the46
256 samples a second, used to represent ECG signals, HR signals have a significantly lower data47
rate. Therefore, HR signals can be communicated easily and cheaply via mobile networks. There is48
a large body of literature which establishes that HR signals can be used for AF detection [14,19–22].49
However, the interpretation of the noise-like HR signals is difficult. Even physicians struggle to detect50
AF through visual inspection of the HR waveform. Furthermore, manual HR interpretation results in51
inter- and intra-operator variability, which deteriorates the diagnosis quality. Hence, computer-based52
diagnosis support systems are compulsory for long-term cardiac monitoring [23]. Currently, the53
most promising approach for manual interpretation of HR signals is to extract diagnostically relevant54
information, in the form of digital bio-markers, from the waveform. Even with the support of digital55
bio-markers, physicians can only analyze short HR traces and the analysis can take longer than the56
heart takes to produce the trace. That makes real-time assessment impossible in a practical setting.57
In this paper we propose hybrid decision support to monitor atrial fibrillation for stroke58
prevention. The monitoring service offers universal access to patient HR data, automated AF detection59
and alarm, physician support and a feedback channel to the patients. The service duration is not60
restricted. That means our service supports arbitrarily long observation duration, which might help to61
detect paroxysmal AF cases. The value proposition for the healthcare providers is twofold. From the62
medical perspective, a long observation duration has the potential to establish a higher AF detection63
rate in patients who use the service. Furthermore, the unrestricted observation duration allows a64
physician to monitor the AF treatment efficacy indefinitely. The second value proposition comes from65
hybrid decision support which leads to efficiency in terms of both time and cost. The reading physician66
gets involved only if a Deep Learning (DL) algorithm detected a sequence of AF beats in the HR67
data; at all other times human intervention is not required. Hence, the AF detection service reduces68
the time a physician spends on routine screening tasks. Once AF is detected, the service provides69
information extraction tools to analyze critical sections of the HR trace effectively. The physician70
can combine the extracted information with other information sources, such as patient records and71
personal interaction with the patient, to reach a safe and reliable diagnosis. This diagnosis can be72
communicated via a feedback channel to the patient. The combination of continuous machine analysis73
and human oversight creates a cost-effective system for hybrid decision support. Executing the AF74
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detection algorithm for real-time monitoring loads a current Central Process Unit (CPU) core about75
50%. This translates into low processing cost if the algorithm runs on a cloud server. Furthermore, the76
low-data rate implies that the wireless heart rate sensors have a low energy consumption, which keeps77
both size and cost down. The value propositions focus on the healthcare provider. The patient benefits78
from the AF detection service through patient-led signal acquisition, unobtrusive HR measurement,79
and peace of mind through real-time HR monitoring and diagnosis.80
To support our value propositions, we have structured the remainder of the paper as follows. The81
next section presents the design steps which led to a prototype implementation. Specific emphasis82
was placed on Internet of Things (IoT) and advanced Artificial Intelligence (AI) techniques. The result83
section details the service prototype implementation. The discussion section provides a comparison84
between the proposed service and existing solutions in the market. The conclusion section summarizes85
our method and highlights the major points of the discussion.86
2. Materials and Methods87
We have used service design principles to analyze and structure the AF detection problem88
[24,25]. First, we considered the needs of all stakeholders affected by the proposed service [26]. This89
understanding shapes the requirements for the AF detection service. The next step is to translate the90
stakeholders’ requirements to system specification for a successful implementation. The validity of91
this specification was tested with a prototype implementation, which incorporates hybrid decision92
support. The following sections provide further details on the individual steps which led to the AF93
detection service creation.94
2.1. Need definition95
To establish a need definition it is necessary to introduce the link between AF detection and stroke96
prevention in more detail. A stroke occurs when there is a lack of oxygen that causes brain tissue97
to die suddenly [27]. For Ischemic stroke, the lack of oxygen is due to a blockage of arteries which98
supply oxygen rich blood to the brain. In most cases, that blockage is caused by plaque debris in the99
bloodstream. The heart pumps blood, and indeed the debris, towards the brain tissue through arteries100
with a decreasing diameter. At one point, the debris will block the artery and that will prevent oxygen101
supply to the connected brain tissue. The occurrence of plaque debris is linked to the fluid dynamics of102
the blood flow which is governed by the beat to beat variability of the human heart. The Framingham103
Heart Study showed that rhythm irregularities, which change the heartbeat variability, increase the104
stroke risk [28]. In particular, the study found that a rhythm irregularity (arrhythmia) known as AF105
increases the stroke risk fivefold.106
With that background, the first service design step was to identify the key stakeholders and their107
needs. We found that there are four key stakeholders in the AF detection service. The sole reason108
for creating the service is the fact that AF exists in patients. Hence, this group has the primary need109
when it comes to AF detection for stroke prevention. Healthcare providers aim to address that need110
by creating an appropriate infrastructure. That infrastructure requires investment based on cost and111
benefits. From an abstract point of view, physicians are part of the infrastructure. Their input is crucial112
when it comes to establishing the benefits of a proposed service. Hence, innovators who create AF113
detection services for stroke prevention must address the need of physicians to establish the benefits of114
their method. However, the effort spent in addressing these needs must be balanced with the required115
profitability for a practical problem solution. Table 1 details the need definition results.116
2.2. Requirements analysis117
Based on the need definition, we have captured the required functionality and the associated118
value proposition. Table 2 summarizes both the requirements and value proposition. Cost efficiency119
and decision support quality are the two most important requirements, because they determine if120
the proposed service can be used to improve and extend existing infrastructure. All subsequent121
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Table 1. Stakeholders AF detection service with hybrid decision support.
Stakeholders Needs and wants
Patients Reduced stroke risk, less clinicalvisits, mobility, safety
Physicians
Improved clinical outcomes, high
quality diagnosis, safety, reduced
workload
Healthcare providers







Table 2. Service requirements and their associated value propositions.
Service Requirement Value proposition
A Cost efficient and decision support
quality
More infrastructure to help a larger number of patients
B Raise an alarm when AF is detected Establishing and communicating a suspicion that AF is
present in real-time
C Present the evidence for raising the
alarm
Providing an overview of the estimated AF probability.
This can be used to review the DL results which established
a suspicion and triggered an alarm message.
D Allow to select a time interval
of interest. Subsequently, the
corresponding HR trace can be
analyzed
Download the HR trace which corresponds to the selected
time interval of interest and calculate features from that
HR trace.
E Provide a feedback channel to the
patient
Act on the diagnosis by providing appropriate and timely
feedback to the patient. Act on meta data, such as data
stream interruptions, to ensure patient compliance.
requirements are functional requirements which answer the question: What service do we build? An122
alarm message should only be sent when AF is detected. This requirement reflects the information123
refinement and management nature of the service. An alarm message has a high information content,124
but a low data rate. This functional specification addresses the requirement for reducing the physician125
workload. To be specific, the work to establish a suspicion that AF is present has shifted from humans126
to machines. The AF detection service is a diagnosis support tool, that means all diagnostic decisions127
lie with the physician. To support that decision, the AF detection service must provide evidence which128
lead to the suspicion that there is a disease present. This can help to ensure both functional safety and129
quality of the diagnosis. It should be possible to provide evidence even if there is no alarm message.130
This can help during root cause analysis, and to improve the service. For example, the proposed131
service failed to detect AF in a specific patient. Having the ability to retrieve evidence in the form of132
raw signals might help to establish what caused that fault. That root cause analysis result is the first133
step to improve the algorithms which provide hybrid decision support. The proposed service should134
also provide a feedback channel which allows the service provider to communicate with the patient.135
That channel can be used to disseminate diagnosis results and send messages which help with patient136
compliance.137
To get a better understanding about the functional requirements of the proposed service, we have138
visualized the service requirements as a sequence of interrelated actions, see Figure 1. These actions139
were orchestrated along a timeline to create a relatable structure which orders the individual events.140
The timeline starts with the healthcare provider, represented by a nurse, registering a patient with141
the AF detection service. Once registered, the patient captures heart rate measurements which are142
relayed via a smartphone to a cloud server [29]. In the cloud server the data is stored and analyzed143
by a DL model [30]. When the analysis results indicate that symptoms of AF were found in the HR144
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Figure 1. Required service functionality over time.
data, the cloud logic will send an alarm message to the assigned physician. That message is sent145
within 5 minutes of the AF event. In response to the alarm message, the physician will review the146
evidence contained in the HR trace and fuse this information with further knowledge and experience147
concerning the patient, in order to reach a diagnosis. If the diagnosis is negative, i.e. the physician148
decides the patient does not have AF, monitoring for AF continues. Once AF is diagnosed, treatment149
can be initiated. The treatment efficacy can now be monitored with the same system setup. If AF is150
diagnosed again, treatment can be adjusted, and the monitoring continues. The next section details the151
functional specification which was created to meet the system requirements.152
2.3. Specification refinement153
The specification establishes how the AF detection service is built. This is done by refining the154
requirements and thereby increasing both clarity and rigor of the documentation. The AF monitoring155
is done by detecting disease related changes in HR signals. These signals are easy to measure, cost156
efficient to communicate, as well as resource efficient to store and process. Hence, this refinement157
addresses the cost efficiency requirement for the proposed service [31]. Using HR signals provides the158
foundation for the functional specification. We have structured the functional specification into six159
service components. The following list details how to build these service components:160
(i) Smart device activation161
The smart device activation service enables a patient’s device to activate and establish an account162
with the healthcare provider. At the start of the service subscription, the healthcare provider163
registers the patient with the database on a cloud server. The unique account contains patient164
information. Necessary fields are: Patient ID, assigned physician, service start date, service end165
date. The registration will provide the cloud server login key. This login key is used for both166
user authentication and data acquisition setup.167
(ii) Cloud server storage168
The patient’s HR data and the DL classification results are stored in the cloud server. This service169
allows the authorized users to retrieve the data anytime and anywhere.170
(iii) Real time HR monitoring service171
The patient wears a breast strap with an embedded HR sensor. The sensor picks up the HR172
signals. These real-time data are displayed on patient smart devices. The patient co-creates value173
by providing and integrating the data into the AF detection service.174
(iv) Automated AF detection and alarm service175
The DL algorithm analyzes patient real time HR data, and classifies the data as AF or non-AF.176
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Figure 2. Architecture of the AF detection system for hybrid decision support.
Once an AF sequence is detected, the system will send an alarm message to the assigned177
physician. The DL algorithm creates the core value for the system.178
(v) Physician diagnosis support service179
The physician support service incorporates algorithm support in the form of DL results and180
diagnosis support tools. It helps the physician to verify the DL results, and to reach a diagnosis.181
The value of this diagnosis is twofold. First and foremost, it helps to initiate treatment which182
might improve outcomes for the patient. A secondary use for an established diagnosis arises183
when we consider improving the DL algorithm. To be specific, a diagnosis becomes ground184
truth which can be used to continuously retrain the DL model. That continued retraining has the185
potential to improve the detection quality of the algorithm.186
(vi) Feedback and intervention service187
Once the physician has reached a diagnosis, the feedback service can be used to communicate188
the result to the patient. Social media, email and personal phone calls can be used to provide189
feedback. Timely appropriate intervention can be carried out to boost the outcomes for patients.190
Another use for the feedback service is the dissemination of patient compliance messages. For191
example, through data analytics it is possible to establish if there is a signal interruption. A192
compliance message over the feedback channel might help to re-establish the data flow.193
3. Results194
This section describes how we translated the specification into an implementation. The service195
components were translated into software processes, executed by standard machine architectures,196
and communicating over available infrastructure. Figure 2 visualizes the data flow between different197
functional entities of the service. The arrangement of the data flow diagram indicates the central role198
of the cloud storage. The HealthCare app relays the sensor data to the cloud storage. The cluster199
computing sources the data from the cloud server and, once the data is analyzed, puts the result back.200
The processes are managed based on information from the real-time database. This information is201
particularly useful to establish the conditions when and to whom an alarm message is sent. This202
functionality is essential to create the hybrid decision support which allows medical experts to work203
efficiently with smart machines. The following sections introduce the functional entities in more detail.204
205
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Figure 3. HeartCare app login screenshot.
Figure 4. Thingspeak data visualization.
3.1. Real-time database206
The patient information management is based on real-time database entries. During the initial207
registration process, a representative of the healthcare provider creates a patient record. That record208
contains patient-specific information, such as username and password as well as system-specific209
information like a cloud server key which unlocks dedicated data channels. After the initial registration,210
a patient can use the username and password to login to the HeartCare app. This authentication211
ensures that the HR measurements are relayed into the patient specific cloud server channels. The212
controller node in the cluster uses the patient records to set up the patient monitors, which analyze the213
HR data in real time. The patient information is also used to manage the alarm message distribution.214
3.2. HeartCare mobile app215
The AF detection service facilitates patient-led data acquisition. Figure 3 shows a screenshot of216
the HeartCare app log in. The background depicts an averaged HR trace measured with a polar H10217
sensor. The dialogue in the foreground requests the user to enter the login data for the Thingspeak218
cloud server [32]. Each patient has a unique API key. Once logged in, the HeartCare app relays the219
HR data from the sensor to the patient-specific RR_interval_data channel on the cloud server. Both220
patient and authorized physicians can access the patient’s data anywhere using the same API key.221
3.3. Cloud storage222
Each patient account has two cloud storage channels. The first channel, called RR_interval_data,223
holds the HR measurements. The content is updated when the HeartCare app relays HR signals to224
the cloud server. The second channel, called AF_detection_result, holds the DL classification results.225
The result channel content is updated when the patient monitor produces a new result. Figure 4 shows226
a patient’s HR data on the Thingspeak cloud server.227
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Figure 5. Flowchart of the classification system.
Once an AF episode is detected by the DL algorithm, the cloud logic will send an alert to the228
assigned physician. Sending the alert message can be facilitated with a range of communication229
channels, such as email, twitter, and instant messages. The message alerts the physician that a230
dangerous condition has occurred, i.e. AF was detected. The physician decision support and diagnosis231
service can be used to review the available evidence and to reach a diagnosis.232
3.4. Patient HR data processing in the cluster233
The cluster executes a patient monitor process for each patient. That process network facilitates a234
real-time data analysis [33]. To accomplish that task, each patient monitor consists of three processes.235
The first process checks if there is new HR data in the RR_interval_data channel on the cloud. The236
new data is passed on to the second node, which executes a DL model. The DL results are passed to237
the third process which relays them to the AF_detection_result channel on the cloud server.238
Processes one and two of the patient monitor handle the data exchange between the cluster and239
the cloud server. The main task for the patient monitor and indeed for the AF detection service is240
real-time HR analysis. We have realized this functionality with an Long Short-Term Memory (LSTM)241
Recurrent Neural Network (RNN) DL model. The model was trained with benchmark data from 20242
patients. The data is available from PhysioNet’s [34] Atrial Fibrillation Database (AFDB) [35]. 10-fold243
cross validation established an accuracy of 98.51%, a specificity of 98.67% and a sensitivity of 98.32%,244
as reported by Faust et al. [14]. A hold-out [36] accuracy of 99% was established with data from245
three patients. Further hold-out tests established that the DL model could detect AF in unknown HR246
data with 92% and 94% accuracy for data from LTAFDB and NDSDB respectively [37]. The physician247
support module makes the DL results available for physicians in the form of a value ranging from 0 to248
1, which indicates the estimated AF probability. Figure 5 shows the design structure of the proposed249
DL system. The DL algorithm is composed of three layers, namely bidirectional LSTM, Global max250
Pooling, and Fully connected; for more information about the algorithm see Faust et al. [14]. The251
simple structure leaves little space for design errors [38]. Furthermore, the implemented DL algorithm252
does not require feature engineering. Hence, there is no information reduction due to feature selection,253
which improves both accuracy and robustness of the performance results [16].254
3.5. Physician support255
Physician diagnosis support is a major service component, which was specified in Section 2.3. The256
implementation of this service component manages the data available on the cloud server. The service257
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component establishes an interface which allows a physician to verify the automated diagnosis results.258
In other words, the physician can analyze the data and either accept or reject the decision reached by259
the AI system. We implemented that service component by extending an existing HR analysis and260
visualization tool. The tool is called the Heart Rate Variability Analysis Software (HRVAS) program,261
originally developed by Ramshur [39] and published under the GNU public license1. We extended262
the program with the ability to download both HR data and the estimated AF probability from the263
cloud server. Having both, the raw data and the DL results, allows a reading physician to review264
the available evidence either through visual inspection or through the use of digital biomarkers. For265
example, visual inspection might reveal fundamental data problems, such as all RR samples having266
the same value. Digital biomarkers can help to confirm the DL decision result. The ability to establish267
independent human verification of the machine learning results is a main component for the proposed268
hybrid decision making process [40].269
Figure 6 shows a screenshot of the extended HRVAS program. A drop-down menu allows the270
user to select the HR signal from a specific patient. The screenshot shows that the signal from patient271
08455 was selected. As such, the signal from that patient was originally downloaded from the AFDB272
on PhysioNet, and subsequently it was uploaded to the cloud server [34,41]. The benchmark data273
allowed us to test the physician diagnosis support service component implementation. The HRVAS274
Graphical User Interface (GUI) displays the DL results in the upper graph on the left. Displaying the275
DL results gives an overview of the estimated AF probability, i.e. the reading physician can determine276
at what time the patient had an increased AF probability. Based on that reading, the physician can277
select a region of interest and view the HR signal, which corresponds to that region, in the second278
window. The HR signals trace is colored in accordance with the estimated AF probability.279
Apart from visual signal inspection, the main purpose of the HRVAS program is to visualize280
digital biomarkers. The workflow unfolds as follows. The physician selects a region of interest on the281
estimated AF probability graph. Once the region is selected, the corresponding HR trace is displayed282
and the digital biomarkers for this region are calculated. The biomarker values are displayed in the283
right part of the HRVAS GUI. The screenshot in Figure 6 shows time domain biomarkers. The HRVAS284
documentation provides more details on the available digital biomarkers [39]. These biomarkers285
are designed to help physicians during the process of validating the DL results and establishing a286
diagnosis.287
3.6. Feedback and intervention288
Once the physician has reached a diagnosis, the feedback and intervention service communicates289
with the concerned patient. Social media, email and personal phone calls can be used to provide290
feedback. One way to structure the feedback content is a simple traffic light system: Green – all is well.291
Orange – take predetermined precautionary action. Red – see your physician immediately.292
4. Discussion293
The system reaches a diagnosis through a hybrid decision-making process [42]. The hybrid294
process offers three main advantages: 1) safety through human checks and balances, 2) significantly295
reduced physician workload, and 3) increased efficiency, which enables real-time diagnosis. The296
hybrid decision-making process is based on analysis results which are condensed to an independent297
first opinion on the data [43]. To be specific, we propose a system where an AI algorithm analyzes298
the available data in real time and a human practitioner only becomes involved if a suspicion is299
established. However, that design choice is only valid if the AI algorithm is very sensitive when it300
comes to the detection of AF in HR signals. Another central requirement is cost efficiency. Furthermore,301
unspecific decision making is not cost effective, because a human expert gets alarmed often and the302
1 https://github.com/jramshur/HRVAS
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Figure 6. Screenshot of the modified HRVAS program.
machine decisions are routinely overruled. Such unnecessary involvement of human expertise would303
be inefficient, and indeed it would be wasteful in terms of time spent rejecting the machine decision,304
which translates into additional cost for the healthcare provider. Hence, we require the decision305
support algorithm to have both high Specificity (SPE) and high Sensitivity (SEN). In effect that leads306
to a high Accuracy (ACC). Table 3 summarizes research work for the automated detection of AF in307
ECG and HR signals. The performance measures, reported in the three columns at the right of the308
table, indicate two points: 1) there is no performance difference between studies based on ECG and309
HR signals 2) both SEN and SPE values are very high. Hence, these algorithms are sufficiently potent310
to justify large-scale AF detection in a practical service environment.311
The proposed AF detection service is based on hybrid decision support which uses advanced AI312
for automated AF detection. The high accuracy of this algorithm sets it apart from other solutions313
currently on the market. The following paragraphs provide some background on current solutions.314
An Apple Watch and iPhone combination can be used to detect irregular pulse. The Apple315
watch measures the pulse. Once the signal is captured, an algorithm chain analyses the data. The316
user receives an alarm message if an irregular pulse is detected. During hold-out validation with317
benchmark data, that system achieved a positive predictive value of 71% (i.e. only 71% of AF detection318
by the Apple Watch were actual AF detection; the remaining 28% AF were not). Based on the same319
measurements, researchers found that 84% of the participants that received irregular pulse messages320
had AF. In a subsequent open study 400,000 users were enrolled. 0.5% of the participants received321
irregular pulse messages. Apart from that pulse-based studies, the Apple watch also features a finger322
ECG sensor with an AF detection function. However, this only works for as long as the user holds323
their fingers on the sensor. This may not be long enough to detect AF.324
All Apple Watch-based health applications are consumer gadgets, which can establish a suspicion325
that AF might be present. This suspicion would need to be confirmed by a physician using a heart rate326
monitoring system.327
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Table 3. Selected arrhythmia detection studies using HR and ECG. Database (DB) used were: MIT-BIH
Atrial Fibrillation Database (afdb), MIT-BIH Arrhythmia Database (mitdb), MIT-BIH Malignant
Ventricular Arrhythmia Database (vfdb), Creighton University Ventricular Tachyarrhythmia Database
(cudb), MIT-BIH Normal Sinus Rhythm Database (nsrdb), MIT-BIH Long Term Database (ltdb),
European ST-T Database (edb), and ecgdb. Hospital data comes from non-publicly accessible databases.
Author year Method Data PerformanceType DB Rhythm ACC SPE SEN







Ivanovic et al., 2019
[45] CNN, LSTM HR Hospital NSR, AF AFL 88 87.09







VFIB, NSR 98.45 99.87 99.27
Faust et al., 2018 [14] LSTM HR afdb AF NSR 98.39 98.32 98.51
Acharya et al., 2017




VFIB, NSR 92.50 98.09 93.13





HR afdb AF NSR 93 95 90
















VFIB, NSR 97.78 99.76 98.82
Hamed and Owis,
2016 [51] DWT, PCA and SVM ECG afdb AF, AFL, NSR 98.43 96.89 98.96
Xia et al., 2018 [52] STFT/SWT withCNN ECG afdb AF 98.63 98.79 97.87
Petrėnas et al., 2015
[53]
Median filter with
threshold HR nsrdb, afdb AF NSR 98.3 97.1




HR ltafdb, afdb,nsrdb AF NSR 96.05 95.07 96.72
Muthuchudar and
Baboo, 2013 [55] UWT NN ECG afdb
AF, VFIB,
NSR 96











ECG mitdb AF, VFIB 99.19 98.25 78.70
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KardiaMobile with KardiaPro can be used to detect AF at home. The system is based on two328
electrodes which measure finger ECG. Based on these signals, the device decides if AF is present. In a329
study with 51 participants, the device had 8% AF yield, i.e. 4 people were subsequently diagnosed330
with AF.331
Like the Apple watch iPhone combination, KardiaMobile is a gadget which establishes a suspicion332
that AF is present. For a subscription fee of £58/mo, it is possible to store the ECG data on a cloud333
service. However, the measurement is not continuous, 30 second ECG snippets are acquired whenever334
a patient activates the device. Based on such ad hoc measurements, the AF detection algorithm might335
miss an AF period. If an AF period is detected the device raises an alarm and it is up to the patient to336
interpret that information.337
Holter monitor with software, such as CardioScan, is the gold standard for AF diagnosis and is338
the standard measurement device used by clinicians. Before a Holter monitor is used, a suspicion is339
established through the experience of a physician or a gadget. In response to this suspicion, a trained340
technician will set up the Holter-monitor (place electrodes on the patient’s chest etc.). Once the setup341
is completed, the patient wears the device for up to 48h. The recorded ECG signal is analyzed once the342
device is returned to the issuing clinic. The Holter service costs £50 for a 10h recording. Apart from the343
cost, Holter monitors have significant drawbacks. The AF detection rate is positively correlated with344
the observation interval, i.e. a longer observation interval increases the probability of detecting AF. The345
data analysis can only start once the Holter monitor is returned; this lack of real-time responsiveness346
becomes a problem should one choose to increase the observation interval significantly. Wearing a347
Holter monitor restricts patients’ mobility. If the electrodes detach, the patient must visit the clinic.348
Our AF detection service offers long observation intervals and real-time computer aided diagnosis.349
The data handling cost is about £30/mo. We envisage that it would replace the Holter system as350
the clinical gold standard for AF diagnosis. With a positive predictive value of 95.40%, our system351
achieved a higher AF detection quality when compared to the competitors. The physician support352
module helps physicians to reach a diagnosis. Establishing a diagnosis and not only a suspicion makes353
timely intervention possible. Table 4 summarizes the comparison of the AF detection service with354
three main competitors.355
4.1. Limitations356
In this paper we outline the design process for a proof of concept AF detection service which357
incorporates hybrid decision support. As such, this does not yet meet all the stakeholder needs. Before358
we can offer a complete service monitoring service to patients, the following problems need to be359
addressed:360
(i) An alarm message is sent when a dangerous situation arises. Initially what constitutes a361
dangerous condition could follow Holter monitoring protocols. For example, an AF event362
is detected when the estimated AF probability is above 0.5 for at least 30 s [59]. However, it is363
not known if such an approach is sensitive and indeed specific enough to capture the stroke risk364
for patients.365
(ii) Obtaining necessary regulatory approvals (not just UK & EU) especially as regulatory366
requirements are increasing significantly with the transition to the much more demanding367
Medical Device Regulations. This can be a long and iterative process.368
(iii) Negotiating and executing mutually beneficial and sustainable agreements with appropriate369
commercial partners.370
(iv) Speed to market. Alternative less sophisticated solutions are already available and new solutions371
are in development.372
4.2. Future work373
Addressing the limitations should start with formulating research questions for future work.374
The proposed hybrid decision support to monitor AF for stroke prevention can help to manage and375
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Table 4. Comparison of the AF detection service with three main competitors.






Quality PPV: 95.40% PPV: 71% (Pulse) 8% AF yield N/R
No. patients 82 N/R 50 N/R
Dataset AFDB & LTAFDB Measurement data Measurement data Measurement data
System properties
Signal Heart Rate ECG Finger ECG ECG
Processing Cloud server Local Cloud server Local
Real-time Yes Yes Yes No
Diagnosis Symbiosis betweenphysician and DL None None Feature support
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Physical
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Apple watch and
iPhone KardiaMobile device Holter monitor






























Safety Human and machine Not critical Not critical Human
Cost
Hardware £ 300 £ 1000 £ 99 and mobile cost £ 1,885.00
Service £ 30 / month Free £ 9.99 / month £ 50 for 10h
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indeed utilize the real time information flow that results from extending the observation duration. The376
prolonged observation duration might lead to new insights about the way in which AF develops in377
the human body. These new insights should be used to improve and adjust the service functionality. It378
might be possible to learn and indeed to formulate how human experts interpret the results which lead379
to a diagnosis. For example, the process generating the alarm message might take into consideration380
patient age, disease history, and severity as well as duration of the AF event.381
For future work, we propose two clinical studies. The first clinical study is designed to build382
trust in the technologies which enable the service functionality. We plan to measure HR and ECG383
from 20 patients at the same time. These measurements will be stored in buffers within the sensors.384
The ECG analysis results will be considered as ground truth with which the automated HR analysis385
results are compared. That will allow us to establish accuracy, sensitivity, and specificity in a practical386
setting. During the second study, we will focus on fine tuning the clinical processes necessary to deal387
with real time HR data. We plan to involve three clinical sites with 20 patients each. We will recruit388
participants with both known and unknown etiology to get deeper insights into the link between HR389
and the nature of embolisms which might lead to stroke [60]. During that study, a patient is only fitted390
with one sensor which communicates HR with a wireless uplink. The wireless uplink will generate391
a real time data stream which is analyzed automatically with a DL algorithm. That implies data is392
transmitted from the patient environment to a medical cloud server. This will require considerable393
planning to safeguard the medical infrastructure.394
Another aspect for future work is reviewing and potentially influencing the regulatory framework395
that governs medical decision support systems. Currently, the UK2 classifies diagnosis support396
algorithms as medical devices for which certification is required. More work is needed to capture the397
learning nature of AI algorithms. To be specific, it is not clear how to establish device safety when398
the functionality changes based on the availability of more data. This is a challenge, not only for the399
medical device regulation agencies, because retraining the algorithm means changing the decision400
support model and hence the device is not the same as the one which was approved. Initially, a service401
provider might train new models and have them certified when they show a measurable improvement402
over the deployed decision support models. In the future, it might be possible to certify the method403
which retrains the learning algorithm. That would shorten the time for patients to benefit from new404
decision support models and it would reduce the administrative effort.405
Using the proposed AF detection service for many patients over long time periods leads to big406
data with reliable labels. With these datasets it might be possible to gain knowledge about deeper407
structural properties of AF, such as the relationship with long-term beat patterns and arrhythmias.408
These structural properties can help to predict and eventually prevent AF for many patients. One409
prerequisite for this ambitious vision is to create an environment which allows for a continuous410
retraining of the DL network. Retraining will gradually improve the DL models in terms of detection411
performance. This will lead to earlier detection of less severe forms of AF. During the retraining412
process it might be possible to identify the beat irregularities which indicate AF onset. We might413
discover AF background, which indicates the presence of the disease, without observing the rhythm414
irregularities.415
The AF detection service success depends on the hybrid decision support functionality which416
establishes the cooperation among human experts and machines. For the proposed setup, the human417
expert is firmly in control. Digital biomarkers allow us to establish the validity of the DL result.418
However, as we move from inference, i.e. detecting AF, to predicting AF these digital biomarkers419
and indeed human expertise are less able to carry out that validation task. There might be no human420
detectable patterns which foreshadow the onset of AF. Hence, the responsibility for the diagnosis shifts421
2 https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/890025/
Software_flow_chart_Ed_1-06_FINAL.pdf
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towards the machine results. This might be ethically acceptable, because predicting AF implies that422
we are dealing with a mild form of the disease which requires only a gentle intervention and results423
in mild or no side effects. Hence, the role of human oversight might vary depending on the severity424
of the intervention. For example, a decision to initiate a treatment through anticoagulation should425
be supported by evidence in the form of physiological signal measurements together with adequate426
human analysis, because the intervention carries the risk of death. If the intervention consists of a427
suggestion to change lifestyle choices such that AF can be avoided, then the requirement for human428
verification might be minimal. We predict that future hybrid decision support structures will offer429
such a nuanced validation approach.430
5. Conclusion431
In this paper we propose hybrid decision support for stroke prevention based on automated AF432
detection in HR signals. Commercial HR sensors are used for data acquisition. The sensor data is433
relayed via mobile phone to a cloud server for data storage. A DL model evaluates the HR data in real434
time. The real-time evaluation results take the form of an estimated AF probability. The physician can435
use that result as a second opinion which might improve the AF diagnosis, which ultimately leads to a436
stroke risk stratification. To support physicians during the diagnosis, we have incorporated DL results437
and digital biomarkers in the proposed GUI to provide two independent analysis results. Having two438
independent results has the advantage that there is no single point of failure and the digital biomarkers439
can be used to validate the DL results.440
Real-time AF monitoring and diagnosis systems are of great interest because they allow an441
early diagnosis, which might improve patient quality of life, and provide a promising alternative to442
current healthcare processes. The value propositions focus on the healthcare provider. The patient443
benefits from the stroke risk monitoring service through patient-led signal acquisition, unobtrusive444
HR measurement, and peace of mind through real-time HR monitoring and diagnosis.445
The proposed real-time stroke risk monitoring service has the potential to provide benefits for446
patients who suffer from heart conditions via accurate automated diagnosis as well as non-intrusive447
and uninterrupted treatment monitoring. It also reduces the healthcare cost by replacing expert with448
machine work. Furthermore, the number of visits to specialized care facilities is kept to a minimum,449
which benefits the patient and keeps costs low.450
Author Contributions: Conceptualization, Ningrong Lei, Murtadha Kareem, U Rajendra Acharya, and Oliver451
Faust; methodology, U Rajendra Acharya; software, Oliver Faust; validation, Seung Moon; investigation, Oliver452
Faust; writing–original draft preparation, Oliver Faust; writing–review and editing, Ningrong Lei, Murtadha453
Kareem, Edward J. Ciaccio, and U Rajendra Acharya; funding acquisition, Ningrong Lei, Murtadha Kareem, and454
Oliver Faust455
Funding: This research was funded by Grow MedTech, grant number PoF000099. The article processing charge456
was funded by MDPI.457
Acknowledgments: We highly appreciate the support from Grow MedTech which helped us to create the458
innovative technology.459
Conflicts of Interest: The authors declare no conflict of interest. The funders had no role in the design of the460
study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to461
publish the results.462
Abbreviations463




AFDB Atrial Fibrillation Database468
AFL Atrial Flutter469
AI Artificial Intelligence470
CPU Central Process Unit471
DB Database472
Version January 21, 2021 submitted to Int. J. Environ. Res. Public Health 16 of 18
DL Deep Learning473
ECG Electrocardiogram474
GUI Graphical User Interface475
HR Heart Rate476
HRVAS Heart Rate Variability Analysis Software477
IoT Internet of Things478
LSTM Long Short-Term Memory479
NSR Normal Sinus Rhythm480




1. Callow, A.D. Cardiovascular disease 2005—the global picture. Vascular pharmacology 2006, 45, 302–307.485
2. O’donnell, M.J.; Xavier, D.; Liu, L.; Zhang, H.; Chin, S.L.; Rao-Melacini, P.; Rangarajan, S.; Islam, S.; Pais, P.;486
McQueen, M.J.; others. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries487
(the INTERSTROKE study): a case-control study. The Lancet 2010, 376, 112–123.488
3. Adams Jr, H.P.; Bendixen, B.H.; Kappelle, L.J.; Biller, J.; Love, B.B.; Gordon, D.L.; Marsh 3rd, E. Classification489
of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org490
10172 in Acute Stroke Treatment. Stroke 1993, 24, 35–41.491
4. Daniel, K.; Wolfe, C.D.; Busch, M.A.; McKevitt, C. What are the social consequences of stroke for492
working-aged adults?: A systematic review. Stroke 2009, 40, e431–e440.493
5. Carroll, K.; Murad, S.; Eliahoo, J.; Majeed, A. Stroke incidence and risk factors in a population-based494
prospective cohort study. Health Statistics Quarterly 2001, 12, 18–26.495
6. Feigin, V.L.; Forouzanfar, M.H.; Krishnamurthi, R.; Mensah, G.A.; Connor, M.; Bennett, D.A.; Moran, A.E.;496
Sacco, R.L.; Anderson, L.; Truelsen, T.; others. Global and regional burden of stroke during 1990–2010:497
findings from the Global Burden of Disease Study 2010. The Lancet 2014, 383, 245–255.498
7. Wolf, P.A.; Abbott, R.D.; Kannel, W.B. Atrial fibrillation as an independent risk factor for stroke: the499
Framingham Study. Stroke 1991, 22, 983–988.500
8. Jamil-Copley, S.; Kanagaratnam, P. Stroke in atrial fibrillation—hope on the horizon? Journal of The Royal501
Society Interface 2010, 7, S765–S769.502
9. Fitzmaurice, D.A.; Hobbs, F.R.; Jowett, S.; Mant, J.; Murray, E.T.; Holder, R.; Raftery, J.; Bryan, S.; Davies,503
M.; Lip, G.Y.; others. Screening versus routine practice in detection of atrial fibrillation in patients aged 65504
or over: cluster randomised controlled trial. Bmj 2007, 335, 383.505
10. Cadilhac, D.A. The economics of atrial fibrillation: a time for review and prioritization. International506
Journal of Stroke 2012, 7, 477–479.507
11. Public Health England. Atrial fibrillation prevalence estimates in England: Application of recent population508
estimates of AF in Sweden. Technical report, National Health Service, 2017.509
12. Kearley, K.; Selwood, M.; Van den Bruel, A.; Thompson, M.; Mant, D.; Hobbs, F.R.; Fitzmaurice, D.;510
Heneghan, C. Triage tests for identifying atrial fibrillation in primary care: a diagnostic accuracy study511
comparing single-lead ECG and modified BP monitors. BMJ open 2014, 4, e004565.512
13. Humphries, K.H.; Kerr, C.R.; Connolly, S.J.; Klein, G.; Boone, J.A.; Green, M.; Sheldon, R.; Talajic, M.;513
Dorian, P.; Newman, D. New-onset atrial fibrillation: sex differences in presentation, treatment, and514
outcome. Circulation 2001, 103, 2365–2370.515
14. Faust, O.; Shenfield, A.; Kareem, M.; San, T.R.; Fujita, H.; Acharya, U.R. Automated detection of atrial516
fibrillation using long short-term memory network with RR interval signals. Computers in biology and517
medicine 2018, 102, 327–335.518
15. Acharya, U.R.; Faust, O.; Ciaccio, E.J.; Koh, J.E.W.; Oh, S.L.; San Tan, R.; Garan, H. Application of nonlinear519
methods to discriminate fractionated electrograms in paroxysmal versus persistent atrial fibrillation.520
Computer Methods and Programs in Biomedicine 2019, 175, 163–178.521
16. Faust, O.; Hagiwara, Y.; Hong, T.J.; Lih, O.S.; Acharya, U.R. Deep learning for healthcare applications522
based on physiological signals: a review. Computer methods and programs in biomedicine 2018.523
17. Rajaganeshan, R.; Ludlam, C.; Francis, D.; Parasramka, S.; Sutton, R. Accuracy in ECG lead placement524
among technicians, nurses, general physicians and cardiologists. International journal of clinical practice525
2008, 62, 65–70.526
Version January 21, 2021 submitted to Int. J. Environ. Res. Public Health 17 of 18
18. Acharya, U.R.; Ghista, D.N.; KuanYi, Z.; Min, L.C.; Ng, E.; Sree, S.V.; Faust, O.; Weidong, L.; Alvin, A.527
Integrated index for cardiac arrythmias diagnosis using entropies as features of heart rate variability signal.528
2011 1st Middle East Conference on Biomedical Engineering. IEEE, 2011, pp. 371–374.529
19. Nguyen, T.T.; Yuldashev, Z.; Sadykova, E. A remote cardiac rhythm monitoring system for detecting530
episodes of atrial fibrillation. Biomedical Engineering 2017, 51, 189–194.531
20. Asgari, S.; Mehrnia, A.; Moussavi, M. Automatic detection of atrial fibrillation using stationary wavelet532
transform and support vector machine. Computers in biology and medicine 2015, 60, 132–142.533
21. Koivisto, T.; Pänkäälä, M.; Hurnanen, T.; Vasankari, T.; Kiviniemi, T.; Saraste, A.; Airaksinen, J. Automatic534
detection of atrial fibrillation using MEMS accelerometer. Computing in Cardiology Conference (CinC),535
2015. IEEE, 2015, pp. 829–832.536
22. Harju, J.; Tarniceriu, A.; Parak, J.; Vehkaoja, A.; Yli-Hankala, A.; Korhonen, I. Monitoring of heart rate537
and inter-beat intervals with wrist plethysmography in patients with atrial fibrillation. Physiological538
measurement 2018, 39, 065007.539
23. Larburu, N.; Lopetegi, T.; Romero, I. Comparative study of algorithms for atrial fibrillation detection.540
Computing in Cardiology, 2011. IEEE, 2011, pp. 265–268.541
24. Erl, T. SOA Principles of Service Design (paperback); Prentice Hall Press, 2016.542
25. Faust, O.; Lei, N.; Chew, E.; Ciaccio, E.J.; Acharya, U.R. A Smart Service Platform for Cost Efficient Cardiac543
Health Monitoring. International Journal of Environmental Research and Public Health 2020, 17, 6313.544
26. Stickdorn, M.; Hormess, M.E.; Lawrence, A.; Schneider, J. This is service design doing: Applying service design545
thinking in the real world; " O’Reilly Media, Inc.", 2018.546
27. Ali, A.N.; Abdelhafiz, A. Clinical and economic implications of AF related stroke. Journal of Atrial547
Fibrillation 2016, 8.548
28. Romero, J.R.; Wolf, P.A. Epidemiology of stroke: legacy of the Framingham Heart Study. Global heart 2013,549
8, 67–75.550
29. Paszkiel, S. Using BCI in IoT Implementation. In Analysis and Classification of EEG Signals for Brain–Computer551
Interfaces; Springer, 2020; pp. 111–128.552
30. Paszkiel, S. Using Neural Networks for Classification of the Changes in the EEG Signal Based on Facial553
Expressions. In Analysis and Classification of EEG Signals for Brain–Computer Interfaces; Springer, 2020; pp.554
41–69.555
31. Faust, O.; Ciaccio, E.J.; Acharya, U.R. A Review of Atrial Fibrillation Detection Methods as a Service.556
International Journal of Environmental Research and Public Health 2020, 17, 3093.557
32. Pasha, S. ThingSpeak based sensing and monitoring system for IoT with Matlab Analysis. International558
Journal of New Technology and Research 2016, 2.559
33. Faust, O.; Yu, W.; Acharya, U.R. The role of real-time in biomedical science: A meta-analysis on560
computational complexity, delay and speedup. Computers in biology and medicine 2015, 58, 73–84.561
34. Goldberger, A.L.; Amaral, L.A.; Glass, L.; Hausdorff, J.M.; Ivanov, P.C.; Mark, R.G.; Mietus, J.E.; Moody,562
G.B.; Peng, C.K.; Stanley, H.E. PhysioBank, PhysioToolkit, and PhysioNet: components of a new research563
resource for complex physiologic signals. Circulation 2000, 101, e215–e220.564
35. Moody, G.; Mark, R. A new method for detecting atrial fibrillation using R-R intervals. Computers in565
Cardiology. Computers in Cardiology, 2005. IEEE, 2005, pp. 227–230.566
36. Yadav, S.; Shukla, S. Analysis of k-fold cross-validation over hold-out validation on colossal datasets for567
quality classification. 2016 IEEE 6th International conference on advanced computing (IACC). IEEE, 2016,568
pp. 78–83.569
37. Faust, O.; Kareem, M.; Shenfield, A.; Ali, A.; Acharya, U.R. Validating the robustness of an internet of570
things based atrial fibrillation detection system. Pattern Recognition Letters 2020, 133, 55–61.571
38. Lih, O.S.; Jahmunah, V.; San, T.R.; Ciaccio, E.J.; Yamakawa, T.; Tanabe, M.; Kobayashi, M.; Faust, O.;572
Acharya, U.R. Comprehensive electrocardiographic diagnosis based on deep learning. Artificial Intelligence573
in Medicine 2020, 103, 101789.574
39. Ramshur, J.T. DESIGN, EVALUATION, AND APPLICAION OF HEART RATE VARIABILITY ANALYSIS575
SOFTWARE (HRVAS). Master’s thesis, The University of Memphis, 2010.576
40. Faust, O. Improving the safety of atrial fibrillation monitoring systems through human verification.577
Biomedical signal processing and control 2014, 13, 295–305.578
Version January 21, 2021 submitted to Int. J. Environ. Res. Public Health 18 of 18
41. Moody, G. A new method for detecting atrial fibrillation using RR intervals. Computers in Cardiology 1983,579
pp. 227–230.580
42. Faust, O.; Ciaccio, E.J.; Majid, A.; Acharya, U.R. Improving the safety of atrial fibrillation monitoring581
systems through human verification. Safety science 2019, 118, 881–886.582
43. Kareem, M.; Faust, O. Establishing the safety of a smart heart health monitoring service through validation.583
2019 IEEE International Conference on Big Data (Big Data). IEEE, 2019, pp. 6089–6091.584
44. Faust, O.; Kareem, M.; Ali, A.; Ciaccio, E.J.; Acharya, U.R. Automated arrhythmia detection based on585
RR-intervals. Knowledge based systems 2020, -, Under review.586
45. Ivanovic, M.D.; Atanasoski, V.; Shvilkin, A.; Hadzievski, L.; Maluckov, A. Deep Learning Approach587
for Highly Specific Atrial Fibrillation and Flutter Detection based on RR Intervals. 2019 41st Annual588
International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE, 2019, pp.589
1780–1783.590
46. Fujita, H.; Cimr, D. Computer aided detection for fibrillations and flutters using deep convolutional neural591
network. Information Sciences 2019, 486, 231–239.592
47. Acharya, U.R.; Fujita, H.; Lih, O.S.; Hagiwara, Y.; Tan, J.H.; Adam, M. Automated detection of arrhythmias593
using different intervals of tachycardia ECG segments with convolutional neural network. Information594
sciences 2017, 405, 81–90.595
48. Henzel, N.; Wróbel, J.; Horoba, K. Atrial fibrillation episodes detection based on classification of heart rate596
derived features. 2017 MIXDES-24th International Conference" Mixed Design of Integrated Circuits and597
Systems. IEEE, 2017, pp. 571–576.598
49. Desai, U.; Martis, R.J.; Acharya, U.R.; Nayak, C.G.; Seshikala, G.; SHETTY K, R. Diagnosis of multiclass599
tachycardia beats using recurrence quantification analysis and ensemble classifiers. Journal of Mechanics in600
Medicine and Biology 2016, 16, 1640005.601
50. Acharya, U.R.; Fujita, H.; Adam, M.; Lih, O.S.; Hong, T.J.; Sudarshan, V.K.; Koh, J.E. Automated602
characterization of arrhythmias using nonlinear features from tachycardia ECG beats. 2016 IEEE603
International Conference on Systems, Man, and Cybernetics (SMC). IEEE, 2016, pp. 000533–000538.604
51. Hamed, I.; Owis, M.I. Automatic arrhythmia detection using support vector machine based on discrete605
wavelet transform. Journal of Medical Imaging and Health Informatics 2016, 6, 204–209.606
52. Xia, Y.; Wulan, N.; Wang, K.; Zhang, H. Detecting atrial fibrillation by deep convolutional neural networks.607
Computers in biology and medicine 2018, 93, 84–92.608
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